Programme delivered in partnership with the Texas Medical Centre Programme will support Aurase Wound Gel for future entry into US market, advancing SolasCure’s mission to transform chronic wound care for…
Funding will be used to further optimize Aurase Wound Gel for future clinical trials SolasCure aims to deliver the first efficacious, cost-effective, and pain-free solution for millions of patients suffering…
Publication in the ‘International Wound Journal’ provides robust validation of the Phase IIa trial data that will enable further clinical studies Study demonstrates proof-of-concept and strong safety profile of Aurase…
Phase IIa clinical trial evaluated Aurase Wound Gel in patients with venous leg ulcers Former Smith+Nephew CMO, Andy Weymann joins as Chairman to support progression of further Phase II clinical…
SolasCure, a Cambridge-based biotech company committed to addressing the pressing issue of inadequate debridement solutions for chronic wounds, has been selected to receive European Innovation Council (EIC) funding. This will…
Funding will support the development of Aurase Wound Gel and progress towardfurther Phase II clinical trials of innovative wound debriding enzyme Cambridge, UK 27 March 2023 – SOLASCURE Ltd (SolasCure),…
SolasCure, a Cambridge-based biotech company developing revolutionary wound-cleaningtechnology, has been named a UK Life Sciences Innovator in a showcase sponsored by the UK’sDepartment for International Trade. Following a rigorous application process,…
Innovative Cambridge biotech company SolasCure, which is developing a revolutionarywound cleaning technology, has published its pre-clinical results with the InternationalWound Journal, showing preliminary evidence that supports its new enzymatic debridementproduct…
David Fairlamb, Director of Regulatory Affairs at SolasCure, has been named as a winner at the TOPRA awards. The awards, organised by The Organisation for Professionals in Regulatory Affairs, are…
SolasCure has been named the winner of the biotech category at the EIT Health Catapult finals in Stockholm. The medical use of Aurase Wound Gel is being developed with the…
SolasCure’s mission is to support healthcare professionals with wound care products that significantly improve the health and wellbeing of patients with chronic wounds
